Drugs / RENESSANS
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01463592 | Jun 2010 → Jun 2013 | chronic hepatitis C virus infection | MTI Medical Private Limited, Pakistan | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RENESSANS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01463592 ↗ |
| Modality | Other / unclassified | “oral formulation of natural iodine compound (Renessans)” NCT01463592 ↗ |
| Route | Oral | “Renessans {oral}” NCT01463592 ↗ |